Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06346392
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-02-28
Brief Title:
AZD0901 Compared With Investigators Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin182
Sponsor:
AstraZeneca
Organization:
AstraZeneca